Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-16

Clinical Trial Update: One Dose Versus Three Weekly Doses of Benzathine Penicillin G for Patients With Early Syphilis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating dosing regimens for benzathine penicillin G in early syphilis comparing one dose vs three weekly doses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benzathine penicillin G (benzathine penicillin G)

Snippet

Sponsor: Jun Li | Conditions: Syphilis | Phase 4 | Status: UNKNOWN